2024 annual financial data
DiaMedica Therapeutics 2024 Operating margin
DiaMedica Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -26,681,000 USD and net income was -24,444,000 USD.
Operating cash flow was -22,076,000 USD.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,681,000 USD
- Net income
- -24,444,000 USD
- Operating cash flow
- -22,076,000 USD